AzTrials
AzTrials

Spinal Cord Injuries (Complete and Incomplete)NCT07204184

Multisite Transspinal Stimulation for Augmenting Recovery in Spinal Cord Injury

A study testing Multisite transspinal stimulation at rest and Multisite transspinal stimulation during robotic gait training in people with Spinal Cord Injuries (Complete and Incomplete), run by Maria Knikou, PT, MBA, PhD at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A well-established rehabilitation strategy for improvements of standing and walking ability in persons with spinal cord injury (SCI) is step training on a motorized treadmill with body weight support. A promising intervention is stimulation of the spinal cord through the skin (transspinal). Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Multisite transspinal stimulation at rest and Multisite transspinal stimulation during robotic gait training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteUnited States
Study dates
19 Feb 2026to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Willingness to comply with all study procedures and availability for the duration of the study.
  • Ability to understand the consent form and sign the consent form.
  • In good general health as evidenced by medical history.
  • Diagnosed with incomplete SCI (AIS B, C, D).
  • Bone mineral density of the hip (proximal femur) T-score <3.5 SD from age- and gender-matched normative data.
  • Lesion above thoracic (T) 10 to ensure absent lower motoneuron lesion.
Show all 11Show fewer
  • The presence of soleus and FCR H-reflexes.
  • Absent permanent ankle joint contractures prevent passive or active ankle movement because corticospinal and spinal excitability is based on the ankle angle. The ankle straps of the Lokomat also require flexible ankle joints.
  • A diagnosis of first time SCI due to trauma, vascular, or orthopedic pathology.
  • Time after SCI of more than 6 months.
  • Stable medical condition without cardiopulmonary disease or cognitive impairment.

Who cannot join

  • Supraspinal lesions.
  • Neuropathies of the peripheral nervous system.
  • Significant degenerative neurological disorders of the spine or spinal cord.
  • Diagnosed with AIS A.
  • Presence of pressure sores.
  • Advanced urinary tract infection.
Show all 10Show fewer
  • Neoplastic or vascular disorders of the spine or spinal cord.
  • Participation in an ongoing research study or new rehabilitation program.
  • Pregnant women or women who suspect they may be or may become pregnant will be excluded from participation because the risks of thoracolumbar stimulation to the fetus are unknown.
  • People with cochlear implants, pacemakers, implanted infusion device, and/or implanted stimulators of any type and purpose will be excluded to avoid their malfunction due to stimulation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

MARIA KNIKOU, PT, MBA, PhD contact

+1-718-982-3316

maria.knikou@csi.cuny.edu

United States1 site, 1 recruiting
  • College of Staten Island (Building 5N-218)

    Staten Island, New York, 10314

    MARIA KNIKOU, PT, MBA, PhD, 718-982-3316, maria.knikou@csi.cuny.edu

    Abdullah M. Sayed Ahmad, MD

    Recruiting

Other trials in United States

About this study

Official title: Cervical and Lumbosacral Transspinal Stimulation to Reconnect the Injured Human Spinal Cord

A well-established rehabilitation strategy for improvements of standing and walking ability in persons with spinal cord injury (SCI) is step training on a motorized treadmill with body weight support. A promising intervention is stimulation of the spinal cord through the skin (transspinal). No single intervention is likely to significantly improve long-term function after SCI on its own. Rather, combinatorial treatments that work synergistically and can be used at different clinical settings is the answer to target recovery in people with SCI. The objective of this clinical trial is to develop a non-invasive combinatorial intervention that can be used worldwide in different clinical settings. The investigators will use cervical and lumbosacral transspinal stimulation to augment the benefits of locomotor training and affect vital body functions after SCI. The investigators will deliver non-invasive cervical and lumbosacral transspinal stimulation alone or with step training to improve upright posture, walking, bladder, sex, and bowel function in persons with incomplete SCI. The noninvasive nature of the intervention holds minimal risk that outweighs the benefits.

Read the detailed description

The main objective of this hypothesis-based and need-driven clinical research trial is to develop novel rehabilitation strategies and impact clinical practice and care for people with spinal cord injury (SCI). The investigators will use non-invasive transspinal stimulation over the cervical and lumbosacral enlargements, the spinal location of arm and leg motor circuits, to augment the benefits of locomotor training and improve recovery of standing and walking ability in individuals with SCI. This trial is a pilot (or small-scale) clinical trial on cervical and lumbosacral transspinal stimulation administered alone at rest or during assisted step training in people with SCI to establish safety and efficacy.

The investigators' specific aims are as follows:

  1. Determine the underlying physiological actions of paired cervical and lumbosacral transspinal stimulation in people with and without SCI. To address Specific Aim 1, in 12 people with incomplete SCI (AIS B, C, D) and 12 healthy control subjects (age and gender match) we will establish the effects of a) cervical transspinal stimulation on soleus H-reflexes and leg transspinal evoked potentials (TEPs), and the effects of lumbosacral transspinal stimulation on flexor carpi radialis (FCR) H-reflexes, and arm TEPs at rest; and b) the effects of cervical and lumbosacral paired transspinal stimulation on joint coordination and muscle synergies during walking on a motorized treadmill (healthy controls) or with a robotic gait system training (Lokomat) in participants with SCI.
  2. Determine if cervical and lumbosacral transspinal stimulation reconnects the injured human spinal cord, strengthens the weak remnant neuronal pathways, and augments the benefits of locomotor training. To address Specific Aim 2, a total of 24 people with incomplete SCI (AIS B, C, D) will be enrolled. Half will receive cervical and lumbosacral transspinal stimulation at rest. The other half of participants will receive cervical and lumbosacral transspinal stimulation during assisted stepping with a robotic gait system (Lokomat 6 Pro®).

Both groups will receive 20 sessions (5 sessions/week) of 1-hr duration each. Cervical and lumbosacral transspinal stimulation will be delivered at 30 Hz at or above paresthesia intensities based on each participant's comfort levels. For both groups, the investigators will establish safety based on adverse events, and efficacy based on clinical assessments and neurophysiological biomarkers. Before and after the intervention the investigators will 1) establish changes in non-somatic vital bladder, bowel, and sexual body functions, 2) perform clinical assessments of spasticity, standing and walking ability, and 3) perform state-of-the-art experiments to establish changes in neurophysiological biomarkers.

The investigators will use neurophysiological biomarkers to probe actions of the proposed intervention (cervical and lumbosacral transspinal stimulation), use combination of interventions, and address safety and efficacy of intervention via adverse events and neurophysiological biomarkers. Furthermore, the investigators will 1) identify and validate biomarkers for diagnosis, prognosis, and evaluation of treatment efficacies, and 2) maximize the function of the residual neural circuitry, including harnessing neuroplasticity and recovery to improve function after SCI.

Being tested
Multisite transspinal stimulation at rest, Multisite transspinal stimulation during robotic gait training
Keywords
transspinal stimulation, robotic gait training, locomotor training, non-invasive, multi-modal rehabilitation, clinical biomarkers, neurophysiological biomarkers, sensorimotor recovery
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multisite transspinal stimulation at restDevice

    Also called transcutaneous spinal cord stimulation, transspinal stimulation, robotic gait training, locomotor training

    The intervention, combined cervical and lumbar transspinal stimulation, will be used for the first time to reconnect the spared neuronal pathways of the injured human spinal cord. The intervention will be administered while at rest lying on the back or during robotic gait training. Cervical and lumbar transspinal stimulation will be delivered via surface active electrodes placed on the back of the neck and on low back, and four returning electrodes placed on each clavicle and iliac crest.

  • Multisite transspinal stimulation during robotic gait trainingDevice

    Also called locomotor training, body weight supported assisted step training

    The intervention, combined cervical and lumbar transspinal stimulation, will be administered during robotic gait training. Cervical and lumbar transspinal stimulation will be delivered via surface active electrodes placed on the back of the neck and on low back, and four returning electrodes placed on each clavicle and iliac crest while participants step with the help of the Lokomat 6 Pro, a robotic device that helps the legs step. Locomotor training will depend on the ability of each participant to step without foot dragging. Over the training course, we will adjust the body weight support, ankle straps position, and leg guidance force. The tension of the ankle straps will be adjusted based on the right and left tibialis anterior muscle strength evaluated every 2 weeks. Body weight support and leg guidance force will be adjusted based on presence or absence of knee buckling during standing.

Study groups in NCT07204184
Study groupRoleWhat they receive
Multisite transspinal stimulation at restActive comparatorCervical and lumbosacral non-invasive transspinal tonic stimulation will be delivered at 30 Hz frequency (charge-balanced, symmetric, biphasic rectangular pulses of a 1-ms width per phase) at paresthesia levels or higher depending on each participant's comfort level while participants rest lying on the back. A total of 20 sessions (weekdays excluding weekends and holidays), each for 1 hour, will be administered.
Receives: Device: Multisite transspinal stimulation at rest
Multisite transspinal stimulation during robotic gait trainingActive comparatorThe investigators will deliver cervical and lumbosacral non-invasive transspinal tonic stimulation at 30 Hz frequency (charge-balanced, symmetric, biphasic rectangular pulses of a 1-ms width per phase) at paresthesia levels or higher depending on each participant's comfort level during assisted stepping with the Lokomat 6 Pro, a robotic device that helps the legs step and provides as needed body weight support. A total of 20 sessions (weekdays excluding weekends and holidays), each for 1 hour, will be administered.
Receives: Device: Multisite transspinal stimulation during robotic gait training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Soleus H-reflex recruitment curve

    Investigators will deliver single pulses of 1 ms duration every 5 seconds at increasing intensities to the posterior tibial nerve behind the knee to assemble the soleus H-reflex recruitment curve. At least 50 responses will be recorded. From the recruitment curve, the investigators will estimate changes in the slope and stimulation intensities for reflex threshold.

    Measured: Before and 1 day after all intervention sessions are completed.

  2. Soleus H-reflex rate-dependent depression

    Soleus H-reflexes following posterior tibial nerve of the right leg behind the knee with a 1-ms pulse randomly at 1, 3, 5, 8, and 10 s inter-pulse intervals will be recorded. At each inter-pulse interval, 15 responses will be recorded. Stimulation will be delivered via a ball shape electrode and responses will be recorded from leg muscles with surface electrodes. The smaller the soleus H-reflex amplitude when evoked every 1 second the larger the spinal inhibition. Recovery of spinal inhibition will be considered when the soleus H-reflex depression at 1 second is statistically significant different before and after the intervention.

    Measured: Before and 1 day after all intervention sessions are completed.

  3. Soleus H-reflex phase-dependent modulation during stepping

    Each participant will step with the assistance of the Lokomat, and the investigators will record soleus H-reflexes randomly across 16 equal time bins into which each step cycle is divided. The posterior tibial nerve behind the knee will be stimulated at motor threshold. Stimulations will be triggered based on the foot switch signal. Under physiological conditions, the soleus H-reflex during walking largely is facilitated during the stance phase and inhibited during the swing phase. Recovery of spinal locomotor circuits will be based on the amplitude of the soleus H-reflex during the stance and swing phases of gait, and how much is facilitated and inhibited during the stance and swing phases after intervention compared to before intervention for each participant.

    Measured: Before and 1 day after all intervention sessions are completed.

  4. Leg transspinal evoked potentials recruitment curves

    The investigators will deliver single 1 ms pulses every 5 seconds at increasing intensities with a surface electrode to the low back to assemble the recruitment curves of transspinal evoked potentials recorded from leg muscles with surface electrodes. Participants will lay on their back on a treatment table. From the recruitment curve, the slope and excitation threshold will be established and the intervention will be considered effective when statistical significant differences on their amplitude between before and after values is established.

    Measured: Before and 1 day after all intervention sessions are completed.

  5. Flexor carpus radialis H-reflex recruitment curve

    The investigators will stimulate the median nerve with a bipolar surface electrode at the elbow with single 1-ms pulses at increasing intensities every 5 seconds while participants are seated. At least 50 responses will be recorded. From the recruitment curve, the slope and excitation threshold will be established. The intervention will be considered effective when statistical significant differences between before and after values is found.

    Measured: Before and 2 days after all intervention sessions are completed.

  6. Flexor carpus radialis H-reflex rate dependent depression

    Flexor carpus radialis H-reflexes following median nerve stimulation with a surface bipolar electrode of the right arm at the elbow with a 1-ms pulse will be recorded randomly at 1, 3, 5, 8, and 10 s inter-pulse intervals. At each inter-pulse interval, 15 responses will be recorded. Responses will be recorded from arm muscles with surface electrodes. Under physiological conditions, the reflex is smaller when evoked every 1 second compared to that evoked every 10 seconds. Recovery of spinal inhibition will be considered when a smaller reflex is evoked every 1 second after the intervention compared to that observed before intervention.

    Measured: Before and 2 days after all intervention sessions are completed.

  7. Arm transspinal evoked potentials recruitment curves

    The investigators will deliver single 1 ms pulses every 5 seconds at increasing intensities to the back of the neck with a surface electrode to assemble the recruitment curves of transspinal evoked potentials recorded from arm muscles with surface electrodes. Participants will lay on their back on a treatment table. From the recruitment curve, the slope and excitation threshold will be established and the intervention will be considered effective when statistical significant differences between before and after intervention is established.

    Measured: Before and 2 days after all intervention sessions are completed.

Secondary outcomes (6)
  1. 2-Minute Walk Test

    The 2-Minute Walk Test is a physical assessment measuring aerobic capacity and endurance. Participants will walk with or without assistive devices as far as possible for two minutes in a hallway. The total distance walked is recorded, and will be compared to normative values for the participant's age and gender to identify potential limitations or track progress over time.

    There is currently no single established Minimal Clinically Important Difference for the 2-minute walk test in people with spinal cord injury. However, a recent study showed that in the subacute phase of rehabilitation a 2-Minute Walk Test Minimal Clinically Important Difference is considered when the increase is 31 meters. However, other research studies indicate that the Minimal Clinically Important Difference can vary significantly depending on the specific patient population, rehabilitation stage, disability level, and age.

    Measured: Before and 1-day after all intervention sessions are completed.

  2. 10-Meter Walk Test

    The 10-Meter Walk Test is a performance measure and assesses the walking speed in meters per second over a short duration. Participants will walk 10 meters and the time needed to cover the 10 meters will be recorded. The minimal clinically important difference for the 10-meter walk test in spinal cord injury is approximately 0.13 m/s, a value established for individuals with incomplete SCI within one year of injury. This means that recovery of walking ability will be based on when the speed is improved by 0.13 m/s.

    Measured: Before and 1-day after all intervention sessions are completed.

  3. Sexual function

    Participants will complete a brief questionnaire on sexual function before and after intervention. The questionnaire is the International Spinal Cord Injury sexual function for male and female. The answers to the questions include: normal, reduced/altered, absent, and unknown/not applicable. Improvement from the intervention will be considered when more "normal" answers replace the "reduced-absent or absent" answers.

    Measured: Before and 1-day after completion of all intervention sessions.

  4. Bladder function

    The Overactive Bladder Symptom Score (OABSS) questionnaire will be answered by the participants before and after intervention to establish recovery or changes of the bladder function. The maximum score is 15 and the minimum score is 0. The smaller the score the better the outcome.

    Measured: Before and 1-day after completion of all intervention sessions.

  5. Bowel function

    The University of Michigan Spinal Cord Injury Model Systems for Bowel function questionnaire will be used to establish recovery or changes. The answers are descriptive including yes or no or at least daily or never. A number 1 will be given to the answer that represents the least impact of bowel function on the quality of life and satisfaction. When the sum of scores is lower by at least 20% after the intervention, it will be regarded as improvements in bowel function.

    Measured: Before and 1-day after all intervention sessions are completed.

  6. Modified Ashworth Scale

    The Modified Ashworth Scale assesses spasticity in the lower extremity. The investigators will apply a quick manual stretch to the ankle. A score from 0 to 4 will be given, where 0 indicates no increase in tone and 4 signifies complete rigidity. A score of 1 or 1+ indicates a slight increase in tone with a catch, while 2 means a marked increase, and 3 signifies a considerable increase that makes passive movement difficult. The maximum score is 4 and the minimum score is 0. The lower the score the better the outcome or recovery. A minimal clinically important difference for the Modified Ashworth Scale is 0.45 for the lower extremity.

    Measured: Before and 1-day after all interventions are completed.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2025
  2. Study start19 Feb 2026
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07204184
Sponsor's protocol ID
C41217GM
Other IDs
C41217GM
Status last verified
Mar 2026
First submitted
10 Sep 2025
Last updated
18 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Limited Individual participant data (IPD) will be shared.

Publications

  • Knikou M, Mummidisetty CK. Locomotor training improves premotoneuronal control after chronic spinal cord injury. J Neurophysiol. 2014 Jun 1;111(11):2264-75. doi: 10.1152/jn.00871.2013. Epub 2014 Mar 5.

    PubMed 24598526
  • Smith AC, Rymer WZ, Knikou M. Locomotor training modifies soleus monosynaptic motoneuron responses in human spinal cord injury. Exp Brain Res. 2015 Jan;233(1):89-103. doi: 10.1007/s00221-014-4094-7. Epub 2014 Sep 10.

    PubMed 25205562
  • Knikou M, Smith AC, Mummidisetty CK. Locomotor training improves reciprocal and nonreciprocal inhibitory control of soleus motoneurons in human spinal cord injury. J Neurophysiol. 2015 Apr 1;113(7):2447-60. doi: 10.1152/jn.00872.2014. Epub 2015 Jan 21.

    PubMed 25609110
  • Murray LM, Knikou M. Remodeling Brain Activity by Repetitive Cervicothoracic Transspinal Stimulation after Human Spinal Cord Injury. Front Neurol. 2017 Feb 20;8:50. doi: 10.3389/fneur.2017.00050. eCollection 2017.

    PubMed 28265259
  • Islam MA, Pulverenti TS, Knikou M. Neuronal Actions of Transspinal Stimulation on Locomotor Networks and Reflex Excitability During Walking in Humans With and Without Spinal Cord Injury. Front Hum Neurosci. 2021 Feb 18;15:620414. doi: 10.3389/fnhum.2021.620414. eCollection 2021.

    PubMed 33679347
  • Zaaya M, Pulverenti TS, Knikou M. Transspinal stimulation and step training alter function of spinal networks in complete spinal cord injury. Spinal Cord Ser Cases. 2021 Jul 3;7(1):55. doi: 10.1038/s41394-021-00421-6.

    PubMed 34218255
  • Sayed Ahmad AM, Zaaya M, Harel NY, Knikou M. Transspinal stimulation preceding assisted step training reorganizes neuronal excitability and function of inhibitory networks in spinal cord injury: A randomized controlled trial. medRxiv [Preprint]. 2025 Jun 12:2025.06.11.25329338. doi: 10.1101/2025.06.11.25329338.

    PubMed 40585100
  • Knikou M, Murray LM. Repeated transspinal stimulation decreases soleus H-reflex excitability and restores spinal inhibition in human spinal cord injury. PLoS One. 2019 Sep 26;14(9):e0223135. doi: 10.1371/journal.pone.0223135. eCollection 2019.

    PubMed 31557238
  • Sayed Ahmad AM, Skiadopoulos A, Knikou M. Interactions between arm and leg neuronal circuits following paired cervical and lumbosacral transspinal stimulation in healthy humans. Exp Brain Res. 2024 Sep;242(9):2229-2239. doi: 10.1007/s00221-024-06891-y. Epub 2024 Jul 22.

    PubMed 39034329

Questions about this trial

What is this clinical trial studying?

A study testing Multisite transspinal stimulation at rest and Multisite transspinal stimulation during robotic gait training in people with Spinal Cord Injuries (Complete and Incomplete), run by Maria Knikou, PT, MBA, PhD at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact MARIA KNIKOU, PT, MBA, PhD (+1-718-982-3316, maria.knikou@csi.cuny.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Soleus H-reflex recruitment curve (time frame: Before and 1 day after all intervention sessions are completed.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07204184, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in